Conmed CORP (CNMD) SEC Filings — 2024
25 SEC filings for Conmed CORP (CNMD) in 2024.
Filings
- CONMED Corp Files 8-K for Other Event — 8-K · Dec 10, 2024
- Conmed CORP SC 13G/A Filing — SC 13G/A · Nov 13, 2024
- Conmed CORP SC 13G/A Filing — SC 13G/A · Nov 12, 2024
- CONMED Corp Files Q3 2024 10-Q — 10-Q · Oct 31, 2024
- CONMED Corp Files 8-K on Operations, Personnel Changes — 8-K · Oct 30, 2024
- CONMED Corp Files 8-K on Operations and Financials — 8-K · Oct 4, 2024
- CONMED Corp Files Routine 8-K Report — 8-K · Sep 30, 2024
- CONMED Corp Announces Executive and Director Changes — 8-K · Sep 20, 2024
- CONMED Corp Files 8-K: Director & Officer Changes — 8-K · Aug 14, 2024
- CONMED Corp Files 8-K Report — 8-K · Aug 9, 2024
- CONMED Corp Files Q2 2024 10-Q — 10-Q · Aug 1, 2024
- CONMED Corp Files 8-K on Financials — 8-K · Jul 31, 2024
- CONMED Appoints Todd W. Simmons as CFO — 8-K · May 28, 2024
- CONMED Corp Files 8-K for Shareholder Votes & Other Events — 8-K · May 22, 2024
- CONMED Corp Files 10-Q for Period Ending March 31, 2024 — 10-Q · Apr 25, 2024
- CONMED CFO Departs, Interim Appointed — 8-K · Apr 24, 2024
- CONMED Corp Files 8-K on Financials — 8-K · Apr 24, 2024
- CONMED Corp Files Definitive Proxy Statement (DEF 14A) — DEF 14A · Apr 8, 2024
- CONMED Corp Files 2023 Annual Report on Form 10-K — 10-K · Feb 28, 2024
- CONMED Files 8-K Current Report on Feb 26 Event — 8-K · Feb 27, 2024
- Vanguard Trims CONMED Stake to 11.7% as of Dec 29, 2023 — SC 13G/A · Feb 13, 2024
- EARNEST Partners Cuts CONMED Stake to 6.1% — SC 13G/A · Feb 12, 2024
- Capital Research Global Investors Trims CONMED Stake to 8.7% — SC 13G/A · Feb 9, 2024
- CONMED Q4 Net Sales Up 10.1% to $340.4M; FY Sales $1.24B — 8-K · Jan 31, 2024
- BlackRock Amends CONMED Stake, Files 19th SC 13G/A — SC 13G/A · Jan 22, 2024